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Frequency and causes of QRS prolongation during
exercise electrocardiogram testing in biventricular
paced patients with heart failureBrett D. Atwater, MD,* Kasper Emerek, MD,† Zak Loring, MD,*
Christoffer Polcwiartek, MD,*† Kevin P. Jackson, MD,* Daniel J. Friedman, MD‡From the *Division of Cardiology, Duke University Medical Center, Durham, North Carolina, †Department
of Clinical Medicine, Aalborg University, Aalborg, Denmark, and ‡Division of Cardiology, Yale
University Medical Center, New Haven, Connecticut.Introduction
Cardiac resynchronization therapy-defibrillator (CRT-D) im-
plantation is associated with improvements in heart failure
(HF) symptoms and all-cause mortality in patients with
symptomatic HF, prolonged QRS duration (QRSd), and left
ventricular ejection fraction (EF) 35%.1–3 Up to 30% of
patients fail to experience improvement in HF symptoms
after CRT-D implantation.4 Greater QRSd reduction during
CRT pacing is associated with improved likelihood of echo-
cardiographic reverse remodeling after implantation of
biventricular (BIV) pacemakers or defibrillators.5 In some
cases, patients have improvement in resting HF symptoms
after CRT-D implantation but continue to experience HF
symptoms during physical exertion. “Optimal” CRT-D pro-
gramming varies considerably between patients and within
individual patients at rest vs during exercise.6 Most CRT-D
devices are programmed empirically, without knowledge of
the patient’s individualized optimal settings, because CRT
optimization at rest and exercise is time-consuming and
expensive and there remains a lack of consensus regarding
the best optimization technique.7 The purpose of this study
was to examine the frequency and causes of QRSd prolonga-
tion during supervised electrocardiogram (ECG) exercise
testing among a group of patients with prior CRT-D implan-
tation.Case report
Study population
This is a retrospective analysis of patients who received a de
novo CRT-D implantation at Duke University Medical Cen-
ter between April 2006 and September 2015. Patients wereKEYWORDS Biventricular pacing; Cardiac resynchronization therapy; Elec-
trophysiology; Exercise testing; QRS interval
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365 days prior to CRT-D implantation demonstrating a left
ventricular EF of 35%, had a digital ECG at baseline
(180 days prior to CRT implantation) demonstrating a
QRSd 120 ms, and underwent a clinically indicated exer-
cise stress test after CRT-D implantation. Patients were
excluded if the resting stress test ECG showed no CRT pac-
ing or if the exercise ECG was too noisy to interpret. PR,
QRS, and QT intervals were measured manually using elec-
tronic calipers at a sweep speed to 50 mm/s and a gain of 15
mm/mV. The study was approved by the Duke Institutional
Review Board.
Patients were longitudinally followed using remote pa-
tient monitoring or in-clinic device interrogation and reports
were stored in PDF format. Device programming was
performed at the discretion of the implanting operator or
following physician based on the patient’s expected or re-
corded physical activity, age, observed or expected
maximum heart rate (HR), and atrioventricular (AV) conduc-
tion time.
Baseline characteristics of the study population were re-
ported using frequencies with percentages for categorical
variables and means with standard deviations or medians
with interquartile range for continuous variables. Statistical
analyses were performed in JMP Pro Version 13.1 (SAS,
Cary, NC).
A total of 1001 patients underwent CRT-D implant during
the study period; 83 patients underwent exercise ECG stress
testing after CRT-D implant. Of these, 25 patients were
excluded because resting ECG demonstrated no CRT pacing
and 1 patient was excluded because resting and exercise
stress ECGs demonstrated noise that prevented accurate mea-
surement, leaving a total of 57 patients available for analyses.
Baseline patient characteristics
Patient characteristics at the time of stress testing are shown
in Table 1. The median time from CRT-D implant to stress
testing was 2.3 (0.7–5.9) years. The median age was 60
(53–69) years, 63% of patients were male, and the majorityen access article
.0/).
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KEY TEACHING POINTS
 Patients with ongoing heart failure symptoms after
cardiac resynchronization therapy-defibrillator
(CRT-D) implantation frequently demonstrated
exercise-induced electrocardiogram (ECG) evidence
of suboptimal CRT pacing during clinically indicated
stress testing. Despite the high frequency of
abnormal findings, the use of exercise ECG testing
in CRT-D recipients was infrequent.
 Common mechanisms of QRS prolongation during
exercise included an exercise heart rate exceeding
the programmed upper tracking rate, progressive
competitive native atrioventricular (AV) nodal
conduction with bundle branch block due to
suboptimal AV interval programming, and
switching from left ventricle–only to biventricular
(BIV) pacing at heart rates above 100 beats per
minute. Device reprogramming could improve CRT
pacing during exercise in these patients.
 Approximately half of all patients with QRS
prolongation during exercise had no obvious
discernible mechanism. More research is needed to
understand possible changes in ventricular
activation that occur during exercise in patients
undergoing BIV pacing.
Table 2 Biventricular implantable cardioverter-defibrillator
device programming at the time of exercise stress test
Days from device interrogation to stress
test -22 (-82 to 16)
Pacing mode, n (%)
Table 1 Demographic and clinical information obtained at the
time of exercise stress test
Age, years 60 (53–69)
Sex, male 36 (63)
Diabetes 20 (35)
Hypertension 32 (56)
Ischemic heart disease 22 (39)
Atrial fibrillation 17 (30)
Underlying QRS duration, ms 162 (146–178)
Underlying PR interval, ms 176 (156–190)
Underlying QRS morphology
LBBB 36
RBBB 6
IVCD 3
RV paced 12
Beta blocker taken on day of stress
Yes 45 (79)
No 9 (16)
Missing 3 (5)
Antiarrhythmic drug taken on day of stress
Amiodarone 9 (16)
Class III 5 (9)
None 43 (75)
Pre-biventricular ICD ejection fraction, % 22 (18–29)
Resting ejection fraction on stress test, % 35 (20–50)
Change in ejection fraction from pre-
biventricular ICD to stress test, %
4 (0–15)
All values are given as n (%) or median (interquartile range).
ICD 5 implantable cardioverter-defibrillator; IVCD 5 nonspecific intra-
ventricular conduction delay LBBB5 left bundle branch block; RBBB5 right
bundle branch block; RV 5 right ventricle.
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raphy was assessed after CRT-D implantation in 36 of 57 pa-
tients. The EF improved after CRT-D implantation by 5%
in 17 of 36 patients (47%) and the left ventricular end-
systolic volume improved by 15% in 16 of 36 patients
(44%). Patients achieved a median BIV pacing percentage
of 99% (97%–100%) but were relatively sedentary with a
median physical activity of 2.6 (1.1–4.4) hours per day
(Table 2).DDD 32 (56)
DDDR 17 (30)
VVIR 8 (14)
Paced AV delay, ms 140 (130–160)
Sensed AV delay, ms 100 (100–120)
Rate-adaptive AV delay
Yes 35 (61)
No 10 (18)
Unknown 12 (21)
Adaptive CRT programmed ON 15 (27)
Lower rate, BPM 60 (50–60)
Upper tracking rate, BPM 130 (130–135)
Upper sensor rate, BPM 130 (120–130)
Patient activity (hours/day) 2.6 (1.1–4.4)
Biventricular pacing, % 98.7 (97–100)
All values are given as n (%) or median (interquartile range).
AV5 atrioventricular; BPM5 beats per minute; CRT 5 cardiac resynch-
ronization therapy.Stress testing
The indication for stress testing was evaluation of ongoing
HF symptoms in 46 patients, symptoms of cardiac ischemia
in 5 patients, and other indications in 6 patients (Table 3).
Stress testing was ordered by a primary care provider in 1
patient, a cardiologist in 14 patients, an HF specialist in 36
patients, and an electrophysiologist in 6 patients. The median
exercise time was 414 (259–540) seconds. Patients obtained
a median peak HR of 125 (110–138) beats per minute (BPM)
and had a median maximum metabolic equivalent of 6.7
(4.4–8.4). The peak heart rate exceeded the programmed up-
per tracking rate in 22 of 49 (45%) patients programmed to
DDD or DDDR mode.ECG findings
The median resting CRT paced QRSd was 152 ms (140–175
ms). The median change in QRSd from underlying conduc-
tion to resting CRT pacing was -12 ms (-25 ms to 117 ms).
At peak exercise, QRSd increased in 37 patients, remained
Figure 1 Frequency of change in QRS duration by 10-millisecond inter-
vals.
Table 3 Results of exercise stress testing
Indication for stress test
Heart failure 46
Ischemia symptoms 5
Other 6
Time from implant to stress test, years 2.3 (0.7–5.9)
Stress protocol
Bruce 12
Ekelund 22
Modified Naughton 19
Other 4
Maximum METs 6.7 (4.4–8.4)
Peak heart rate (BPM) 125 (110–138)
Resting BIV-paced QRSd (ms) 152 (140–175)
Peak exercise QRSd (ms) 160 (152–176)
Change in QRSd from rest to peak
exercise (ms)
10 (-7 to 128)
Resting BIV-paced PR interval (ms) 154 (140–171)
Peak exercise PR interval (ms) 132 (119–160)
Change in PR interval from rest to peak
exercise (ms)
-14 (-40 to 18)
Resting QT interval (ms) 454 (420–480)
Peak exercise QT interval (ms) 374 (354–400)
Change in QT interval from rest to peak
exercise (ms)
-66 (-98 to -48)
All values are given as n (%) or median (interquartile range).
BIV 5 biventricular; BPM 5 beats per minute; METs 5 metabolic
equivalents.
310 Heart Rhythm Case Reports, Vol 6, No 6, June 2020unchanged in 3 patients, and decreased in 17 patients. The
median change in QRSd at peak exercise compared to rest
was 110 ms (-7 ms to 128 ms). Twenty-nine patients
(50%) had an increase in QRSd of 10 ms and 20 patients
(34%) had an increase in QRSd of 20 ms from rest to
peak exercise (Figure 1). Fifteen patients had a gradual in-
crease in QRSd from rest to peak exercise, the cause of which
could not be determined. Eleven patients had a sudden in-
crease in QRSd with change in QRS morphology as the exer-
cise HR exceeded the upper tracking rate; 9 patients had a
sudden, initially intermittent increase in QRSd with a change
inQRSmorphology below the upper tracking rate with loss of
ventricular pacing output as the PR interval became shorter
than the sensed AV delay. Among these 9 patients, 6 had
either a rate-adaptive AV interval feature or Adaptive CRT
(Medtronic plc, Dublin, Ireland) programmed on. Two
patients had a sudden increase in QRSd with change in
QRS morphology after the HR exceeded 100 BPM and had
Adaptive CRT programmed on, consistent with automated
change from left ventricle–only pacing to BIV pacing with
the Adaptive CRT algorithm. Examples of ECG changes
associated with each cause are shown in Figure 2. Among
those patients with a sudden change increase in QRSd during
exercise testing (n 5 22), the median time from QRSd in-
crease to peak exercise was 94 (18–278) seconds.
The median change in PR interval from rest to peak exer-
cise was -14 ms (-40 ms to18 ms), while the median change
in QT interval was -66 ms (-98 ms to -48 ms). All patients in
the study (57/57) received CRT-D device follow-up in our
center after stress testing. Seven of 37 patients (19%) with
QRSd prolongation at peak exercise had their upper trackingrate or AV intervals reprogrammed within 1 year of their
stress test.Discussion
We used stress ECG data to examine the frequency and causes
of QRSd prolongation during exercise after CRT-D implanta-
tion. Our population was composed of patients who initially
met Class I or II indication for CRT-D implantation8,9 with pre-
implantation QRSd prolongation, subsequently received a high
BIV pacing percentage, and demonstrated resting ECG evi-
dence of successful CRT. Almost half of the subjects demon-
strated .5% improvement in resting EF or .15% reduction
in left ventricular end-systolic volume, suggesting that they ob-
tained benefit from CRT-D implantation. Despite objective ev-
idence of CRT-D “response,” the device-derived activity
monitoring data showed that the patients remained relatively
sedentary afterCRT-D implantation andongoingHFsymptoms
were the indication for stress testing in the majority of cases.
Themajority of the study population took beta-blocker pre-
scriptions on the day of their stress test, limiting the likelihood
of developing sinus tachycardia or accelerated AV nodal con-
duction with exertion. Despite this, the majority of studied
patients attained a peak heart rate that exceeded their pro-
grammed upper tracking rate or developed competing AV
nodal conduction with underlying bundle branch block.
In our study, only 7 of 39 patients with QRSd prolongation
during stress testing received CRT programming changes to
improve CRT pacing during exercise. It is possible that
QRSd prolongation was not noted during the stress ECG
interpretation. In our study few of the exercise tests were or-
dered by an electrophysiologist, and the treating electrophys-
iologist may not have been aware of the results. Given the
frequency of QRSd prolongation among CRT-paced patients
and the fact that the majority of identified cases could poten-
tially have been corrected with device reprogramming,
review by the treating electrophysiologist should be encour-
aged. Alternatively, the development of automated device
features to identify exercise-induced loss of CRT and iterative
automated device reprogramming to improve CRT pacing
during exercise may provide improvement of CRT delivery
during varying physiological conditions.
Figure 2 Representative electrocardiogram (ECG) examples highlighting common causes of QRS prolongation with exercise. A1, B1, C1: Resting cardiac
resynchronization therapy–paced ECGs on 3 patients. A2: Intermittent loss of ventricular pacing spikes with associated intermittent QRS prolongation. This re-
sulted from reduction in native PR interval to less than the sensed atrioventricular (AV) delay in a patient without rate-adaptive AV delay programmed on. As the
patient continued to exercise, ventricular pacing was lost entirely. B2: Ongoing biventricular pacing but with more prolonged QRS duration after the heart rate
increases beyond 100 beats per minute. At this rate, the Adaptive CRT (Medtronic plc) algorithm automatically switched from left ventricle only to biventricular
pacing, resulting in QRS prolongation.C2:Absence of ventricular pacing with underlying left bundle branch block conduction and QRSwidening, resulting from
an atrial rate exceeding the programmed upper tracking rate.
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exercise. Further evaluation of the mechanisms of QRSd
reduction during exercise is warranted.
Limitations
The study is limited by the retrospective, single-center design.
All patients had a clinical indication for stress testing. It remains
unclear how frequently QRSd prolongation occurs during exer-
cise amonga lesscarefully selectedCRTpopulation.Aprospec-
tive study of routine exercise ECG testing in a population of
patients with CRT pacing would improve understanding of
the incidence among CRT recipients. Stress echocardiography
images were available in only 16 of 57 patients, limiting our
ability to study associations between exercise-induced QRSd
prolongation and ventricular function.Conclusions
CRT recipients with ongoing symptoms of HF or cardiac
ischemia frequently demonstrate prolongation of QRSd
during exercise ECG testing, suggesting that CRT pacing
may be less effective during exercise compared to rest. The
majority of these cases could be corrected with CRT device
reprogramming.References
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